Recently, it was reported that PDE4 inhibitors possess antiproliferative effects, and inhibit the tumour cell growth of several types of cancers; thus, PDE4 inhibitors are a promising novel target for cancer therapy.18–27. Here, PDE4A is linked to cancer.